Effects of a Test Food for Cognitive Functio

Not Applicable

• Conditions: /A(healthy adults)

• Registration Number: JPRN-UMIN000039097
• Lead Sponsor: MORINAGA & CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-21
• Study Completion: 2020-02-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Not provided

Exclusion Criteria

1)Individuals using medical products. 2)Individuals with dementia or sleep disorder. 3)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 4)Individuals who contract or have a history of serious gastrointestinal disease. 5)Individuals who have an addiction to alcohol or a mental illness. 6)Individuals who used a drug for treatment of disease in the past 1 month. 7)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae: Dactylis glomerata, Phleum pratense) 8)Individuals who contract or have a history of food allergy. 9)Individuals with serious anemia. 10)Individuals with high blood glucose (fasting blood glucose over 126 mg/dL). 11)Individuals who are a smoker. 12)Females who are or are possibly pregnant, or are lactating. 13)Individuals whose life style will change during the test period. 14)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 15)Individuals who had a habit to ingest foods claiming to improve cognitive function, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 16)Individuals who had a habit to use drug claiming to improve cognitive function in the past 3 months. 17)Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 18)Individuals who participated in other clinical studies in the past 1 months. 19)Individuals judged inappropriate for the study by the principal.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Japanese version of the CNS Vital Signs (Cognitrax)

Secondary Outcome Measures

Name	Time	Method
Doctor's questions, blood glucose